Cas 129504-30-9,Pentanoic acid, 5-oxo-5-[[5-[(phenylmethyl)thio]-1,3,4-thiadiazol-2-yl]amino]-, methyl ester

129504-30-9

Post Buying Request

Basic information

Product Name: Pentanoic acid, 5-oxo-5-[[5-[(phenylmethyl)thio]-1,3,4-thiadiazol-2-yl]amino]-, methyl ester
Synonyms:
CAS NO:129504-30-9
Molecular Formula: C15H17N3O3S2
Molecular Weight: 351.45
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Pentanoic acid, 5-oxo-5-[[5-[(phenylmethyl)thio]-1,3,4-thiadiazol-2-yl]amino]-, methyl ester(CAS DataBase Reference)
NIST Chemistry Reference: Pentanoic acid, 5-oxo-5-[[5-[(phenylmethyl)thio]-1,3,4-thiadiazol-2-yl]amino]-, methyl ester(129504-30-9)
EPA Substance Registry System: Pentanoic acid, 5-oxo-5-[[5-[(phenylmethyl)thio]-1,3,4-thiadiazol-2-yl]amino]-, methyl ester(129504-30-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 129504-30-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

129504-30-9 Suppliers

Recommended suppliers

129504-30-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 129504-30-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,9,5,0 and 4 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 129504-30:
(8*1)+(7*2)+(6*9)+(5*5)+(4*0)+(3*4)+(2*3)+(1*0)=119
119 % 10 = 9
So 129504-30-9 is a valid CAS Registry Number.

129504-30-9Upstream product

129504-30-9Downstream Products

129504-30-9Relevant academic research and scientific papers

Acetazolamide-like carbonic anhydrase inhibitors with topical ocular hypotensive activity

Antonaroli,Bianco,Brufani,Cellai,Lo Baido,Potier,Bonomi,Perfetti,Fiaschi,Segre

, p. 2697 - 2703 (2007/10/02)

New carbonic anhydrase (EC 4.2.1.1) inhibitors were synthesized as potential drugs for the topical treatment of glaucoma. They were obtained by substituting the acetyl group of acetazolamide and methazolamide with bicarboxylic acids of different chain len

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 129504-30-9